Stock Market

RBC starts Oracle at Neutral on competition concerns

Investing | Thu, Oct 24 2024 12:41 AM AEDT

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz

Investing.com -- RBC Capital analysts initiated coverage of Oracle Corporation (NYSE:ORCL) with a Sector Perform rating and a $165 price target, expressing concerns about rising competition and the sustainability of some recent growth drivers.

"While we like Oracle's market leadership position in database and ongoing cloud transformation, we have concerns about competition and the sustainability of some recent growth drivers, particularly OCI and GenAI," RBC wrote.

Oracle's core database business remains a key asset, according to the bank, but they believe it faces mounting challenges from multiple fronts.

Competition on multiple fronts continues to get stronger, including hyperscale cloud vendors (AWS/Azure/GCP), MongoDB (NASDAQ:MDB), PostgreSQL, and NewSQL vendors, RBC noted.

The firm added that while pricing may support growth, Oracle's net new workload growth could be limited moving forward.

Oracle Cloud Infrastructure (OCI) has shown impressive growth, reaching $8.6 billion in annual recurring revenue (ARR) with a 54% growth rate, according to RBC estimates.

However, analysts remain cautious about the future of OCI.

"We have concerns over the sustainability of this growth, especially for non-Oracle customers," RBC wrote, adding skepticism that OCI can become "the fourth hyperscaler," especially given its much smaller size compared to competitors like AWS and Azure.

RBC also highlighted Oracle Fusion as one of the company's more promising growth engines, particularly within financials.

"Customers view the product favorably, and partners believe the product remains ahead of the competition," the analysts wrote. However, they expect Workday (NASDAQ:WDAY) Financials to close the gap over time.

Although the firm is bullish on generative AI (GenAI) technology, it is skeptical of Oracle's ability to capture significant value from it.

"Our checks support our skepticism on Oracle's GenAI announcements, especially when compared to the innovation taking place at Microsoft (NASDAQ:MSFT)," RBC noted.

With Oracle trading at all-time highs of around $175, RBC's price target of $165 reflects a more cautious outlook, citing Oracle's "relatively slower EPS growth" compared to peers.

This article first appeared in Investing.com

PRNews

Vantiva and e& Deploy First eSIM-enabled 5G Fixed Wireless Access Gateway for United Arab Emirates Subscribers

More powerful Customer Premise Equipment improves wireless service area by 40%;Introduces self-installation and automated antenna optimization PARIS, Oct. 24, 2024 /PRNewswire/ -- ...

Cision | Thu, Oct 24 2024 03:00 AM AEDT

Read More
Stock Market

Apple, Goldman Sachs ordered by CFPB to pay $89M related to Apple Card

Investing.com --The Consumer Financial Protection Bureau (CFPB) revealed Wednesday that it has ordered Apple (NASDAQ:AAPL) and Goldman Sachs (...

Investing | Thu, Oct 24 2024 02:53 AM AEDT

Read More
World News

Otis Among World’s Best Employers

FARMINGTON, Conn., October 23, 2024 /3BL/ - Otis strives to be a world-class employer where colleagues work together to create new ideas ...

3BL | Thu, Oct 24 2024 02:30 AM AEDT

Read More
Stock Market

Coinbase shares to remain rangebound: B Riley

Investing.com -- B Riley analysts initiated coverage of Coinbase (NASDAQ:COIN) with a Neutral rating on Wednesday, expressing optimism ...

Investing | Thu, Oct 24 2024 02:17 AM AEDT

Read More
PRNews

CorDx Selects MasterControl to Streamline Life Science Quality and Manufacturing Processes Globally

IVD leader adopts MasterControl Qx and Mx platforms to ensure regulatory compliance across China, the US and more. SINGAPORE, Oct. 23, 2024 /...

Cision | Thu, Oct 24 2024 02:17 AM AEDT

Read More